Cypress Pharmaceutical Inc. | Currax Pharmaceuticals | off-label or unapproved promotion of medical products | 2012 | FDA | $2,800,000 |
Amgen, Inc. | Amgen | benefit plan administrator violation | 2017 | private lawsuit-federal | $2,750,000 |
Novartis Pharmaceuticals Corp. | Novartis | False Claims Act and related | 2012 | KY-AG | $2,750,000 |
Aegerion Pharmaceuticals Inc. | Amryt Pharma | False Claims Act and related | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,700,000 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | wage and hour violation | 2024 | private lawsuit-federal | $2,700,000 |
EMD Millipore Corporation | Merck KGaA (EMD) | pesticide violation | 2013 | EPA | $2,681,500 |
EMD MILLLIPORE CORP | Merck KGaA (EMD) | environmental violation | 2013 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,681,500 |
Pfizer Inc. | Pfizer | False Claims Act and related | 2011 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,621,154 |
AstraZeneca Pharmaceuticals | AstraZeneca | False Claims Act and related | 2009 | DOJ_CIVIL | $2,600,000 |
Genentech | Roche | wage and hour violation | 2011 | private lawsuit-state | $2,600,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,600,000 |
GlaxoSmithKline | GSK plc | False Claims Act and related | 2012 | ID-AG | $2,600,000 |
Mylan Inc. | Viatris | False Claims Act and related | 2010 | MA-AG | $2,600,000 |
Eisai Co. | Eisai | price-fixing or anti-competitive practices | 2000 | CA-AG | $2,544,900 |
Alpharma, Inc. | Pfizer | price-fixing or anti-competitive practices | 2004 | FTC | $2,500,000 |
AstraZeneca Pharmaceuticals LP and AstraZeneca LP | AstraZeneca | False Claims Act and related | 2011 | ID-AG | $2,500,000 |
Dey Inc. | Viatris | False Claims Act and related | 2005 | CT-AG | $2,500,000 |
Forest Laboratories LLC | AbbVie | False Claims Act and related | 2016 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,500,000 |
Pharmacia Corporation | Pfizer | False Claims Act and related | 2011 | NY-AG | $2,500,000 |
Pfizer Inc. | Pfizer | employment discrimination | 2023 | OFCCP | $2,500,000 |
Teva Pharmaceuticals USA | Teva Pharmaceutical Industries | environmental violation | 2013 | MO-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,402,793 |
Amgen, Inc. | Amgen | False Claims Act and related | 2009 | KY-AG | $2,400,000 |
Roxane Laboratories Inc. | Hikma Pharmaceuticals | False Claims Act and related | 2009 | OH-AG | $2,400,000 |
Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | MA-AG | $2,400,000 |
Johnson & Johnson Consumer Companies, Inc. | Johnson & Johnson | consumer protection violation | 2019 | private lawsuit-federal | $2,400,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | environmental violation | 2009 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,328,154 |
Endo International plc | Endo International | price-fixing or anti-competitive practices | 2019 | MULTI-AG | $2,300,000 |
Ranbaxy Laboratories | Sun Pharmaceuticals | drug or medical equipment safety violation | 2014 | OR-AG | $2,300,000 |
Aventis Pharmaceuticals, Inc. and Aventis Behring, LLC | Sanofi | False Claims Act and related | 2012 | KY-AG | $2,290,000 |
Merck KGaA | Merck KGaA (EMD) | price-fixing or anti-competitive practices | 2009 | MULTI-AG | $2,275,454 |
UCB Pharma, Inc. | UCB | price-fixing or anti-competitive practices | 2009 | MULTI-AG | $2,275,454 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | air pollution violation | 2013 | EPA | $2,250,000 |
GNC Holdings Inc. | Harbin Pharmaceutical Group | drug or medical equipment safety violation | 2016 | FDA | $2,250,000 |
Novel Laboratories Inc. | Lupin Limited | Controlled Substances Act violation | 2024 | DEA | $2,250,000 |
TEVA PHARMACEUTICALS USA INC | Teva Pharmaceutical Industries | environmental violation | 2013 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,250,000 |
King Pharmaceuticals LLC | Pfizer | air pollution violation | 2013 | EPA | $2,200,000 |
Genentech Inc. | Roche | False Claims Act and related | 2016 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,200,000 |
OSI Pharmaceuticals LLC | Astellas Pharma | False Claims Act and related | 2016 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,200,000 |
KING PHARMACEUTICALS | Pfizer | environmental violation | 2013 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,200,000 |
Purdue Pharma L.P. | Purdue Pharma | consumer protection violation | 2002 | FL-AG | $2,150,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2009 | FTC | $2,100,000 |
Genentech | Roche | wage and hour violation | 2012 | private lawsuit-state | $2,100,000 |
Barr Pharmaceuticals Inc. | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $2,100,000 |
Warner Chilcott Holdings Company | AbbVie | price-fixing or anti-competitive practices | 2007 | private lawsuit-federal | $2,100,000 |
Wyeth | Pfizer | price-fixing or anti-competitive practices | 2005 | private lawsuit-federal | $2,100,000 |
Alpharma USPD, Inc., | Teva Pharmaceutical Industries | False Claims Act and related | 2011 | MS-AG | $2,010,667 |
Par Pharmaceutical Co. | Endo International | False Claims Act and related | 2011 | MS-AG | $2,010,667 |
Purepac Pharmaceutical Co., n/k/a Actavis Elizabeth, LLC | Pfizer | False Claims Act and related | 2011 | MS-AG | $2,010,667 |
Wyeth | Pfizer | benefit plan administrator violation | 2013 | private lawsuit-federal | $2,000,000 |
Alere Inc. | Abbott Laboratories | kickbacks and bribery | 2017 | MS-AG | $2,000,000 |
Amgen Inc. | Amgen | False Claims Act and related | 2008 | WI-AG | $2,000,000 |
Barr Laboratories, Inc. and Duramed Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2007 | MA-AG | $2,000,000 |
Dey Pharmaceuticals | Viatris | False Claims Act and related | 2011 | PA-AG | $2,000,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2010 | WI-AG | $2,000,000 |
Johnson & Johnson | Johnson & Johnson | False Claims Act and related | 2011 | ID-AG | $2,000,000 |
Perrigo | Perrigo | False Claims Act and related | 2013 | LA-AG | $2,000,000 |
Takeda Pharmaceuticals | Takeda Pharmaceutical | False Claims Act and related | 2008 | AL-AG | $2,000,000 |
Mutual Pharmaceutical Company, Inc. | Sun Pharmaceuticals | price-fixing or anti-competitive practices | 2015 | private lawsuit-federal | $2,000,000 |
Pharmavite LLC | Otsuka Pharmaceutical | wage and hour violation | 2017 | private lawsuit-state | $1,925,000 |
General Nutrition | Harbin Pharmaceutical Group | wage and hour violation | 2007 | private lawsuit-federal | $1,910,000 |
Teva Pharmaceuticals USA, Inc., Ivax Corp., Ivax Pharmaceuticals, Inc., and Barr Laboratories, Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2010 | ID-AG | $1,900,000 |
Valeant Pharmaceuticals, Inc. | Bausch Health | insurance violation | 2018 | CA-INS | $1,875,000 |
Shire LLC | Takeda Pharmaceutical | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $1,850,000 |
AbbVie Inc. | AbbVie | kickbacks and bribery | 2018 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,800,000 |
Anda | Teva Pharmaceutical Industries | Controlled Substances Act violation | 2016 | WV-AG | $1,800,000 |
Boehringer Ingelheim Roxane, Inc. | Hikma Pharmaceuticals | False Claims Act and related | 2008 | MA-AG | $1,800,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2009 | IA-AG | $1,800,000 |
Neutrogena Corporation | Johnson & Johnson | consumer protection violation | 2013 | private lawsuit-federal | $1,800,000 |
Sigma Aldrich Research Biochemicals Inc. | Merck KGaA (EMD) | export control violation | 2002 | BIS | $1,760,000 |
Forest Pharmaceuticals Inc. | AbbVie | False Claims Act and related | 2012 | KY-AG | $1,750,000 |
Sandoz Inc. | Sandoz Group | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $1,750,000 |
Bristol-Myers Squibb Company and Apothecon, Inc. | Bristol-Myers Squibb | False Claims Act and related | 2008 | ID-AG | $1,738,719 |
Novo Nordisk Inc. | Novo Holdings A/S | False Claims Act and related | 2011 | USAO | $1,725,000 |
Otsuka American Pharmaceutical Inc. | Otsuka Pharmaceutical | off-label or unapproved promotion of medical products | 2008 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,700,000 |
Par Pharmaceutical Cos., Inc. | Endo International | False Claims Act and related | 2011 | ID-AG | $1,700,000 |
Watson Pharmaceuticals Inc. and Watson Pharma Inc. | Teva Pharmaceutical Industries | False Claims Act and related | 2012 | ID-AG | $1,700,000 |
Aventis Pharmaceuticals, Inc. | Sanofi | price-fixing or anti-competitive practices | 2012 | MULTI-AG | $1,650,000 |
Eli Lilly | Eli Lilly | False Claims Act and related | 2013 | LA-AG | $1,650,000 |
Sandoz Inc. | Sandoz Group | False Claims Act and related | 2010 | ID-AG | $1,650,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | consumer protection violation | 2019 | WV-AG | $1,600,000 |
Merck Sharp & Dohme Corp. | Merck | False Claims Act and related | 2011 | ID-AG | $1,600,000 |
Purdue Frederick Co. | Purdue Pharma | False Claims Act and related | 2008 | TX-AG | $1,600,000 |
Sanofi-Aventis | Sanofi | consumer protection violation | 2019 | WV-AG | $1,600,000 |
Merck | Merck | environmental violation | 2011 | EPA | $1,500,000 |
MERCK & CO., INC. | Merck | environmental violation | 2011 | EPA | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $1,500,000 |
Daiichi Pharmaceutical | Daiichi Sankyo | price-fixing or anti-competitive practices | 2000 | CA-AG | $1,446,700 |
Teva Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | consumer protection violation | 2023 | KY-AG | $1,407,000 |
Boehringer Ingleheim | Boehringer Ingelheim | False Claims Act and related | 2011 | KS-AG | $1,400,000 |
SmithKline Beecham Corp. | GSK plc | False Claims Act and related | 2007 | TX-AG | $1,400,000 |
Pfizer | Pfizer | employment discrimination | 2009 | private lawsuit-federal | $1,365,003 |
Abbott Laboratories Inc. | AbbVie | False Claims Act and related | 2009 | OH-AG | $1,340,000 |
Aventis Pharmaceuticals Inc. | Sanofi | False Claims Act and related | 2010 | NJ-AG | $1,300,000 |
GlaxoSmithKline | GSK plc | price-fixing or anti-competitive practices | 2023 | IN-AG | $1,270,000 |
Advanced Sterilization Products, a division of Ethicon Inc. | Johnson & Johnson | drug or medical equipment safety violation | 2013 | FDA | $1,200,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2007 | HI-AG | $1,150,000 |
Lupin Ltd. | Lupin Limited | price-fixing or anti-competitive practices | 2017 | private lawsuit-federal | $1,143,750 |
Astellas | Astellas Pharma | False Claims Act and related | 2013 | LA-AG | $1,130,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | price-fixing or anti-competitive practices | 2008 | MULTI-AG | $1,100,000 |
Novo Nordisk Inc. | Novo Holdings A/S | off-label or unapproved promotion of medical products | 2017 | CA-INS | $1,100,000 |
Actavis Elizabeth LLC | Teva Pharmaceutical Industries | price-fixing or anti-competitive practices | 2022 | private lawsuit-federal | $1,100,000 |
Dey, Inc. | Viatris | False Claims Act and related | 2006 | ID-AG | $1,072,700 |